Bruce Gil

New single-dose vials of 2.5 mg and 5 mg doses of Zepbound will also help alleviate supply constraints for the popular treatment

The United States, the biggest buyer of weight loss drugs, didn't crack the top 10

The WHO shared its plan to combat a Mpox outbreak in Africa that it recently declared an international public health emergency

Viking Therapeutics is developing both a weight loss injection and a weight loss pill

Mark Schneider has decided to step down from his role as CEO after leading the food and beverage giant for eight years

The least expensive show on the list cost Disney $12 million per episode to make

Current Disney CEO Bob Iger is set to step down from his role — for the second time — in 2026.

The media giant named board member James Gorman as chair of a succession planning committee

Deadly recalls from around the world underscore the critical importance of proper sanitation throughout every stage of food production and distribution

The chain could launch the service later this year, with a gameshow and more unscripted content in the works, per Deadline

Success by Sesame is now offering compounded semaglutide for $250 a month

The monthly subscription fee for a standard, ad-free Netflix plan has risen 94% over the last 13 years

The FDA had previously opened an investigation into the issue

The streaming giant said its upfront ad sales commitments soared 150%

The trial results build on previous studies that suggest Zepbound may have additional health benefits aside from weight loss

Arkansas-based NOWDiagnostics plans to launch its 'First To Know' blood test later this year

Pfizer expects cancer drugs developed by Seagen, the biotech company it acquired last year, to generate $10 billion in sales by 2030

Perdue has recalled thousands of pounds of frozen chicken nuggets and chicken tender products

Johnson & Johnson and Roche topped S&P Global's ratings for the strongest pharma companies in the world

The firm wants to team up with a big pharma company to help develop and commercialize it weight loss drug petrelintide

Harris also proposed faster Medicare drug-price negotiations, a $35 cap on out-of-pocket costs for insulin, and cancelling medical debt

The Brooklyn-based Cresilon expects to launch its Traumagel product later this year

Lawyers for Disney are arguing that the terms of a Disney+ trial prevent a plaintiff from taking the company to court

Bavarian Nordic and Emergent Biosoltions surged after WHO rang the alarm regarding a Mpox outbreak